Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Select a Mutual Fund
Risk | Very High | - |
Rating | 3.0 | - |
Min SIP Amount | ₹99 | - |
Expense Ratio | 1.93 | - |
NAV | ₹37.30 | - |
Fund Started | 11 Jun 2018 | - |
Fund Size | ₹2770.21 Cr | - |
Exit Load | Exit load of 1% if redeemed within 1 year. | - |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 36.97% | - |
3 Year | 18.15% | - |
5 Year | 28.29% | - |
1 Year
3 Year
5 Year
Equity | 99.08% | - |
Cash | 0.92% | - |
Equity
Cash
Top 10 Holdings |
| - |
Top 10 Holdings
Name | Assets |
---|---|
Sun Pharmaceutical Industries Ltd. | 12.00% |
Aurobindo Pharma Ltd. | 8.05% |
Cipla Ltd. | 6.80% |
Glenmark Pharmaceuticals Ltd. | 6.20% |
Dr. Reddy's Laboratories Ltd. | 6.05% |
Apollo Hospitals Enterprise Ltd. | 5.51% |
Lupin Ltd. | 5.30% |
Divi's Laboratories Ltd. | 4.96% |
Suven Pharmaceuticals Ltd. | 4.22% |
Krishna Institute of Medical Sciences Ltd | 3.95% |
Name | Vrijesh Kasera | - |
Start Date | 03 Feb 2023 | - |
Name
Start Date
Description | The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India. | - |
Launch Date | 11 Jun 2018 | - |
Description
Launch Date